Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbits

John W Barrett1, Steven J Werden, Fuan Wang

  • 1Biotherapeutics Research Group, Robarts Research Institute and Department of Microbiology and Immunology, University of Western Ontario, London, Ontario N6A 5K8, Canada.

Virus Research
|May 30, 2009
PubMed

Insights

Myxoma virus (MV) uses the M130R protein to cause lethal myxomatosis in rabbits. Deleting this gene makes the virus less harmful, allowing rabbits to fight infection.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Myxoma virus (MV) causes lethal myxomatosis in European rabbits.
  • Understanding viral immunomodulatory genes is crucial for controlling MV.
  • The M130R protein is a unique, late-expressed, non-essential MV gene.

Purpose of the Study:

  • To investigate the role of the M130R gene in MV pathogenesis.
  • To determine if M130R is a virulence factor in myxomatosis.

Main Methods:

  • Constructed a targeted gene knockout virus (vMyx130KO) lacking the M130R gene.
  • Infected susceptible rabbits with wild-type MV and vMyx130KO.
  • Assessed the virulence and host immune response to both viral strains.

Main Results:

  • The M130R knockout virus (vMyx130KO) was significantly attenuated compared to wild-type MV.
  • Loss of M130R expression enabled the rabbit host immune system to control the infection.
  • M130R is essential for the full lethal development of myxomatosis.

Conclusions:

  • The M130R protein is a critical poxviral virulence factor.
  • Targeting M130R could be a strategy for developing attenuated myxoma virus vaccines or therapeutics.